520 related articles for article (PubMed ID: 8842450)
1. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
[TBL] [Abstract][Full Text] [Related]
2. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
[TBL] [Abstract][Full Text] [Related]
3. Role of the phosphatidylinositol-specific phospholipase C pathway in delta-opioid receptor-mediated antinociception in the mouse spinal cord.
Narita M; Ohsawa M; Mizoguchi H; Aoki T; Suzuki T; Tseng LF
Neuroscience; 2000; 99(2):327-31. PubMed ID: 10938438
[TBL] [Abstract][Full Text] [Related]
4. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo.
Qi JA; Mosberg HI; Porreca F
Life Sci; 1990; 47(11):PL43-7. PubMed ID: 2170791
[TBL] [Abstract][Full Text] [Related]
6. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of spinal delta-opioid receptors in mice selectively enhances the attenuation of delta-opioid receptor-mediated antinociception by antisense oligodeoxynucleotide.
Narita M; Tseng LF
Eur J Pharmacol; 1995 Sep; 284(1-2):185-9. PubMed ID: 8549623
[TBL] [Abstract][Full Text] [Related]
8. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
9. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat.
Ossipov MH; Kovelowski CJ; Nichols ML; Hruby VJ; Porreca F
Pain; 1995 Sep; 62(3):287-293. PubMed ID: 8657428
[TBL] [Abstract][Full Text] [Related]
10. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F
J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by mu- but not epsilon-opioid receptor agonist in the mouse.
Narita M; Ohsawa M; Mizoguchi H; Kamei J; Tseng LF
Neuroscience; 1997 Jan; 76(1):291-8. PubMed ID: 8971779
[TBL] [Abstract][Full Text] [Related]
12. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
[TBL] [Abstract][Full Text] [Related]
13. Pseudoirreversible binding characteristics of [D-Ala2,Glu4]deltorphin and its Cys4 substituted derivative to delta-opioid receptors.
Wild KD; Horan PJ; Misicka A; Lipkowski A; Haaseth RC; Matsunaga TO; Hruby VJ; Toth G; Borsodi A; Yamamura HI
Eur J Pharmacol; 1993 Jun; 246(1):25-31. PubMed ID: 8394818
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
15. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
Vanderah T; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Hruby VJ; Haaseth RC; Matsunaga TO; Porreca F
Eur J Pharmacol; 1994 Feb; 252(2):133-7. PubMed ID: 8157053
[TBL] [Abstract][Full Text] [Related]
16. Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats.
Crook TJ; Kitchen I; Hill RG
Br J Pharmacol; 1992 Oct; 107(2):573-6. PubMed ID: 1330187
[TBL] [Abstract][Full Text] [Related]
17. Use of antisense oligodeoxynucleotide to delta-opioid receptor mRNA in the study of turnover of delta-opioid receptors in the spinal cord of the mouse.
Narita M; Mizoguchi H; Nagase H; Tseng LF
Psychopharmacology (Berl); 1997 Oct; 133(4):347-50. PubMed ID: 9372533
[TBL] [Abstract][Full Text] [Related]
18. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
Mattia A; Vanderah T; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Aug; 258(2):583-7. PubMed ID: 1650835
[TBL] [Abstract][Full Text] [Related]
19. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
Sofuoglu M; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1991 May; 257(2):676-80. PubMed ID: 1851833
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse.
Narita M; Narita M; Mizoguchi H; Tseng LF
Eur J Pharmacol; 1995 Jul; 280(2):R1-3. PubMed ID: 7589170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
